UK markets closed

Lotus Pharmaceuticals, Inc. (LTUS)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00500.0000 (0.00%)
At close: 10:06AM EDT

Lotus Pharmaceuticals, Inc.

813 Blue Ridge Drive
Suite 198
Nashville, TN 37207
United States
615 310 2688
https://lotuspharmaceuticalsusa.com

Sector(s)Financial Services
IndustryShell Companies
Full-time employees233

Key executives

NameTitlePayExercisedYear born
Dr. Zhong Yi LiuFounder, Chairman, Chief Executive Officer and President180kN/A1961
Ms. Yan ZengChief Financial Officer and Principal Accounting OfficerN/AN/A1969
Dr. Xing ShenVice President of Corporate DevelopmentN/AN/A1971
Amounts are as of 31 December 2010, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the People's Republic of China. The company is based in Nashville, Tennessee.

Corporate governance

Lotus Pharmaceuticals, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.